Free Trial
OTC:NPRRF

Nipro (NPRRF) Stock Price, News & Analysis

$8.50
0.00 (0.00%)
(As of 03/24/2023)
Today's Range
$8.50
$8.50
50-Day Range
$8.50
$8.50
52-Week Range
$8.50
$8.50
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company's Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. Its Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, and syringes; tube glass; and other parts of pharmaceutical packaging, such as rubber plugs, as well as provides glass for thermos bottles, and lighting and containers. The company also offers business management services. It serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

NPRRF Stock Price History

NPRRF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive NPRRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nipro and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Yoshihiko Sano
    Pres & Representative Director
  • Mr. Takehito Yogo (Age 55)
    CFO, Deputy GM of Corp. Planning Division, Mang. of Corp. Planning Dept, MD & Director
  • Mr. Akihiko Yamabe
    Mang. of Accounting Department - Corp. Planning Division
  • Hideto Nakamura
    GM of Gen. Affairs & HR, Mang. of Personnel Dept and Director
  • Mr. Kiyotaka Yoshioka (Age 54)
    Chief of Bus. Strategy Office, MD, Mang. of Domestic Bus. Dept and Director
  • Mr. Toshiaki Masuda (Age 77)
    Chief of Gen. Research Office, MD, Mngr of Planning Dev Technology Bus. Dept & Director
  • Mr. Tsuyoshi Yamazaki (Age 55)
    Chief of Global Strategy Office, Mang. of the MP Glass Bus. Department, MD & Director
  • Mr. Kimihito Minoura
    MD & Director
  • Mr. Kazuhiko Sano
    Chief of Production Technology Center, Assistant Mang. of Production Bus. Dept, MD & Director
  • Mr. Kenichi Nishida
    Pharmaceutical Devel. Promotion Mang. of Pharmaceutical Bus. Department, MD & Director

NPRRF Stock Analysis - Frequently Asked Questions

How have NPRRF shares performed in 2024?

Nipro's stock was trading at $8.50 on January 1st, 2024. Since then, NPRRF shares have increased by 0.0% and is now trading at $8.50.
View the best growth stocks for 2024 here
.

How do I buy shares of Nipro?

Shares of NPRRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTC:NPRRF) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners